Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial

Author:

Cevik Muge,Thompson Lindsay C,Upton Caryn,Rolla Valéria Cavalcanti,Malahleha Mookho,Mmbaga Blandina,Ngubane Nosipho,Abu Bakar Zamzurina,Rassool Mohammed,Variava Ebrahim,Dawson Rodney,Staples Suzanne,Lalloo Umesh,Louw Cheryl,Conradie Francesca,Eristavi Marika,Samoilova Anastasia,Skornyakov Sergey N,Ntinginya Niyanda Elias,Haraka Frederick,Praygod George,Mayanja-Kizza Harriett,Caoili Janice,Balanag Vincent,Dalcolmo Margareth Pretti,McHugh Timothy,Hunt Robert,Solanki Priya,Bateson Anna,Crook Angela M,Fabiane Stella,Timm Juliano,Sun Eugene,Spigelman Melvin,Sloan Derek J,Gillespie Stephen H,Bruinenberg Paul,Beumont Maria,Nedelman Jerry,Li Mengchun,Zuma-Gwala Ntokozo,Rajaram Shakira,Choo Louise,Wills Genevive,Betteridge Matt,Leandra Leandra,Olugbosi Morounfolu,Borisov Sergey

Funder

European and Developing Countries Clinical Trials Partnership

Federal Ministry of Education and Research Bonn Office

US Agency for International Development

Irish Aid

UK Government Foreign Commonwealth & Development Office

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3